Two Networks of Centres of Excellence (NCEs), the Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and AllerGen NCE (Allergy, Genes and Environment Network of Centres of Excellence), are working together to develop blood tests that will …
Technology at the Fingertips for Better Patient Care: The PROOF Centre and IO Informatics to Develop a Web-Based App
The PROOF Centre and IO Informatics are putting their heads together to develop new tools for clinicians to address chronic heart, lung and kidney disease.
The collaboration brings together the PROOF Centre’s award-winning science and IO Informatics’ leading software and …
One Step Closer to the Clinic: PROOF Centre and HTG Molecular Diagnostics Partner to Commercialize COPD Test
The PROOF Centre has granted HTG Molecular Diagnostics exclusive rights to commercialize PROOF Centre-developed gene expression blood tests for the prognosis of patients with Chronic Obstructive Pulmonary Disease (COPD) who will experience frequent exacerbations (“lung attacks”).
The PROOF Centre – …
PROOF trainee wins award for best oral presentation at the 16th Annual Transplant Research Day
A hearty congratulations to our trainee, Casey Shannon, who won one of the two awards given out for the best oral presentation at the 16th Annual Transplant Research Day that took place on December 3, 2012. In his presentation …
A More Promising Way to Diagnose Acute Rejection in Kidney Transplant Recipients
The latest publication by the PROOF Centre indicates that proteo-genomic biomarker ensemble classifiers show promise in the diagnosis of acute rejection in kidney transplant recipients, and can improve classification performance beyond that of individual genomic or proteomic classifiers alone. Click …